Deceleration capacity: A novel predictor for total mortality in patients with non-ischemic dilated cardiomyopathy

Int J Cardiol. 2016 Oct 15:221:289-93. doi: 10.1016/j.ijcard.2016.06.205. Epub 2016 Jun 27.

Abstract

Objectives: We hypothesized that deceleration capacity (DC), a novel marker of cardiac autonomic modulation, is an independent predictor for mortality in patients with non-ischemic dilated cardiomyopathy (NICM).

Background: NICM is associated with a high risk for sudden cardiac death (SCD). However there are no clinically established parameters available for risk stratification beyond LVEF. DC has been previously shown to be a strong independent predictor for total mortality in patients after myocardial infarction.

Methods: Holter-ECG recordings of 201 patients NICM (83.1% male, mean age: 61.4years, mean LVEF: 33.3%) were analyzed by the method of phase-rectified-signal-averaging (PRSA) to obtain DC.

Results: During a minimum follow-up of 40month 59 patients died. Kaplan Meyer Analysis showed a significantly higher mortality in patients with a DC below 4.5ms (log rank p=0.012) irrespective to the presence of atrial fibrillation.

Conclusions: Impaired DC is a powerful independent predictor for mortality in patients with NICM.

Keywords: Deceleration capacity; Heart rate variability; Non ischemic dilated cardiomyopathy.

MeSH terms

  • Aged
  • Cardiomyopathy, Dilated / diagnosis*
  • Cardiomyopathy, Dilated / mortality*
  • Cardiomyopathy, Dilated / physiopathology
  • Deceleration*
  • Electrocardiography, Ambulatory / mortality
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Mortality / trends
  • Predictive Value of Tests
  • Stroke Volume / physiology